Arkolith/Insider Trading/ABCL/Form 4

Lecault Veronique

Chief Operating Officer, DirectorAbCellera Biologics Inc. (ABCL) · full profile →Form 4 · filed Sep 14, 2023
Net Buying
Open-Market Buys
$104K
Open-Market Sells
$0
Net Open-Market Flow
$104K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 12, 2023Buy(P)20K$5.19$104K2.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001703057-23-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML